ELV logo

Elevance Health, Inc. (ELV) EBIT

annual EBIT:

$7.90B+$189.00M(+2.45%)
December 31, 2024

Summary

  • As of today (August 26, 2025), ELV annual earnings before interest & taxes is $7.90 billion, with the most recent change of +$189.00 million (+2.45%) on December 31, 2024.
  • During the last 3 years, ELV annual EBIT has fallen by -$21.00 million (-0.26%).
  • ELV annual EBIT is now -0.26% below its all-time high of $7.92 billion, reached on December 31, 2021.

Performance

ELV EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVincome statement metrics

quarterly EBIT:

$2.29B-$505.00M(-18.06%)
June 30, 2025

Summary

  • As of today (August 26, 2025), ELV quarterly earnings before interest & taxes is $2.29 billion, with the most recent change of -$505.00 million (-18.06%) on June 30, 2025.
  • Over the past year, ELV quarterly EBIT has dropped by -$694.00 million (-23.24%).
  • ELV quarterly EBIT is now -47.19% below its all-time high of $4.34 billion, reached on December 31, 2009.

Performance

ELV quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVincome statement metrics

TTM EBIT:

$7.07B-$694.00M(-8.94%)
June 30, 2025

Summary

  • As of today (August 26, 2025), ELV TTM earnings before interest & taxes is $7.07 billion, with the most recent change of -$694.00 million (-8.94%) on June 30, 2025.
  • Over the past year, ELV TTM EBIT has dropped by -$1.51 billion (-17.62%).
  • ELV TTM EBIT is now -17.62% below its all-time high of $8.58 billion, reached on June 30, 2024.

Performance

ELV TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

ELV EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+2.5%-23.2%-17.6%
3 y3 years-0.3%+8.0%-9.7%
5 y5 years+32.1%-27.2%-9.7%

ELV EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-0.3%+4.0%-23.2%+278.2%-17.6%at low
5 y5-year-0.3%+32.1%-27.2%+489.2%-17.6%+27.8%
alltimeall time-0.3%>+9999.0%-47.2%>+9999.0%-17.6%>+9999.0%

ELV EBIT History

DateAnnualQuarterlyTTM
Jun 2025
-
$2.29B(-18.1%)
$7.07B(-8.9%)
Mar 2025
-
$2.80B(+361.6%)
$7.76B(-1.8%)
Dec 2024
$7.90B(+2.4%)
$606.00M(-55.9%)
$7.90B(-4.8%)
Sep 2024
-
$1.37B(-54.0%)
$8.30B(-3.3%)
Jun 2024
-
$2.99B(+1.6%)
$8.58B(+6.8%)
Mar 2024
-
$2.94B(+193.6%)
$8.04B(+4.1%)
Dec 2023
$7.71B(+1.5%)
$1.00B(-39.5%)
$7.71B(-0.6%)
Sep 2023
-
$1.65B(-32.2%)
$7.76B(-5.7%)
Jun 2023
-
$2.44B(-6.8%)
$8.23B(+4.0%)
Mar 2023
-
$2.62B(+150.6%)
$7.91B(+4.1%)
Dec 2022
$7.60B(-4.1%)
$1.04B(-50.9%)
$7.60B(-4.5%)
Sep 2022
-
$2.13B(+0.2%)
$7.96B(+1.7%)
Jun 2022
-
$2.12B(-8.0%)
$7.82B(-2.9%)
Mar 2022
-
$2.31B(+64.7%)
$8.05B(+1.6%)
Dec 2021
$7.92B(+27.0%)
$1.40B(-29.9%)
$7.92B(+11.1%)
Sep 2021
-
$2.00B(-15.2%)
$7.14B(+29.1%)
Jun 2021
-
$2.35B(+8.1%)
$5.53B(-12.6%)
Mar 2021
-
$2.18B(+256.1%)
$6.33B(+1.4%)
Dec 2020
$6.24B(+4.2%)
$611.00M(+57.1%)
$6.24B(-7.2%)
Sep 2020
-
$389.00M(-87.6%)
$6.72B(-14.1%)
Jun 2020
-
$3.15B(+50.7%)
$7.83B(+27.7%)
Mar 2020
-
$2.09B(+90.3%)
$6.13B(+2.4%)
Dec 2019
$5.99B(+18.1%)
$1.10B(-26.3%)
$5.99B(+10.2%)
Sep 2019
-
$1.49B(+2.5%)
$5.43B(+4.8%)
Jun 2019
-
$1.45B(-25.3%)
$5.18B(-1.0%)
Mar 2019
-
$1.95B(+258.2%)
$5.23B(+3.2%)
Dec 2018
$5.07B(+27.9%)
$543.00M(-56.3%)
$5.07B(+9.0%)
Sep 2018
-
$1.24B(-17.4%)
$4.65B(+2.7%)
Jun 2018
-
$1.50B(-15.5%)
$4.53B(+7.0%)
Mar 2018
-
$1.78B(+1333.4%)
$4.23B(+6.7%)
Dec 2017
$3.96B(-13.0%)
$124.20M(-88.9%)
$3.96B(-11.9%)
Sep 2017
-
$1.12B(-7.2%)
$4.50B(-0.4%)
Jun 2017
-
$1.21B(-20.4%)
$4.52B(-5.1%)
Mar 2017
-
$1.51B(+130.0%)
$4.76B(+4.5%)
Dec 2016
$4.56B(-1.6%)
$658.60M(-42.1%)
$4.56B(+6.7%)
Sep 2016
-
$1.14B(-21.5%)
$4.27B(+0.2%)
Jun 2016
-
$1.45B(+10.4%)
$4.26B(-2.5%)
Mar 2016
-
$1.31B(+250.5%)
$4.37B(-5.6%)
Dec 2015
$4.63B(+6.0%)
$374.30M(-66.9%)
$4.63B(-10.0%)
Sep 2015
-
$1.13B(-27.5%)
$5.14B(+0.8%)
Jun 2015
-
$1.56B(-0.7%)
$5.10B(+6.1%)
Mar 2015
-
$1.57B(+76.9%)
$4.81B(+10.1%)
Dec 2014
$4.37B(+13.7%)
$887.10M(-18.4%)
$4.37B(+10.8%)
Sep 2014
-
$1.09B(-14.0%)
$3.94B(+5.6%)
Jun 2014
-
$1.26B(+11.8%)
$3.73B(+1.5%)
Mar 2014
-
$1.13B(+145.8%)
$3.68B(-4.0%)
Dec 2013
$3.84B(-0.5%)
$459.80M(-47.7%)
$3.83B(-0.6%)
Sep 2013
-
$879.70M(-27.2%)
$3.85B(-3.7%)
Jun 2013
-
$1.21B(-5.8%)
$4.00B(+4.2%)
Mar 2013
-
$1.28B(+166.4%)
$3.84B(-0.7%)
Dec 2012
$3.86B(-2.5%)
$481.40M(-53.1%)
$3.87B(+0.1%)
Sep 2012
-
$1.03B(-2.2%)
$3.86B(-0.5%)
Jun 2012
-
$1.05B(-19.9%)
$3.88B(+1.1%)
Mar 2012
-
$1.31B(+173.9%)
$3.84B(-3.0%)
Dec 2011
$3.96B
$478.20M(-54.2%)
$3.96B(-6.5%)
DateAnnualQuarterlyTTM
Sep 2011
-
$1.05B(+3.8%)
$4.23B(-2.1%)
Jun 2011
-
$1.01B(-29.4%)
$4.32B(-2.7%)
Mar 2011
-
$1.43B(+89.7%)
$4.45B(+2.1%)
Dec 2010
$4.35B(-41.2%)
$752.10M(-33.8%)
$4.35B(-45.2%)
Sep 2010
-
$1.14B(+0.6%)
$7.94B(+0.2%)
Jun 2010
-
$1.13B(-15.4%)
$7.92B(+1.0%)
Mar 2010
-
$1.34B(-69.2%)
$7.84B(+6.0%)
Dec 2009
$7.40B(+137.1%)
$4.34B(+288.4%)
$7.40B(+107.3%)
Sep 2009
-
$1.12B(+6.1%)
$3.57B(+18.9%)
Jun 2009
-
$1.05B(+17.8%)
$3.00B(-4.3%)
Mar 2009
-
$893.60M(+76.0%)
$3.14B(+0.5%)
Dec 2008
$3.12B(-40.6%)
$507.80M(-7.6%)
$3.12B(-20.7%)
Sep 2008
-
$549.40M(-53.7%)
$3.94B(-17.3%)
Jun 2008
-
$1.19B(+34.9%)
$4.76B(-2.7%)
Mar 2008
-
$879.20M(-33.5%)
$4.89B(-7.0%)
Dec 2007
$5.26B(+7.0%)
$1.32B(-3.5%)
$5.26B(+0.7%)
Sep 2007
-
$1.37B(+4.1%)
$5.22B(+2.3%)
Jun 2007
-
$1.32B(+5.7%)
$5.10B(+2.3%)
Mar 2007
-
$1.25B(-2.9%)
$4.99B(+1.5%)
Dec 2006
$4.91B(+26.3%)
$1.28B(+2.3%)
$4.91B(+5.2%)
Sep 2006
-
$1.25B(+4.3%)
$4.67B(+5.2%)
Jun 2006
-
$1.20B(+2.6%)
$4.44B(+7.4%)
Mar 2006
-
$1.17B(+12.6%)
$4.13B(+6.3%)
Dec 2005
$3.89B(+169.5%)
$1.04B(+1.8%)
$3.89B(+22.9%)
Sep 2005
-
$1.02B(+14.1%)
$3.17B(+25.8%)
Jun 2005
-
$896.60M(-3.5%)
$2.52B(+26.9%)
Mar 2005
-
$928.90M(+192.7%)
$1.98B(+37.1%)
Dec 2004
$1.44B(+18.4%)
$317.40M(-15.2%)
$1.45B(-0.7%)
Sep 2004
-
$374.10M(+3.0%)
$1.46B(+4.6%)
Jun 2004
-
$363.20M(-7.5%)
$1.39B(+6.5%)
Mar 2004
-
$392.60M(+19.8%)
$1.31B(+7.4%)
Dec 2003
$1.22B(+51.0%)
$327.80M(+5.7%)
$1.22B(+5.0%)
Sep 2003
-
$310.20M(+11.3%)
$1.16B(+7.5%)
Jun 2003
-
$278.60M(-7.9%)
$1.08B(+12.4%)
Mar 2003
-
$302.50M(+12.3%)
$960.60M(+18.9%)
Dec 2002
$807.60M(+53.9%)
$269.40M(+17.4%)
$807.60M(+19.5%)
Sep 2002
-
$229.40M(+44.0%)
$676.00M(+8.4%)
Jun 2002
-
$159.30M(+6.6%)
$623.70M(+9.5%)
Mar 2002
-
$149.50M(+8.5%)
$569.80M(+8.6%)
Dec 2001
$524.60M(+66.6%)
$137.80M(-22.2%)
$524.60M(+35.6%)
Sep 2001
-
$177.10M(+68.0%)
$386.80M(+84.5%)
Jun 2001
-
$105.40M(+1.1%)
$209.70M(+101.1%)
Mar 2001
-
$104.30M(>+9900.0%)
$104.30M(>+9900.0%)
Dec 2000
$314.90M(+417.9%)
-
-
Dec 2000
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2000
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2000
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2000
-
$0.00(0.0%)
$0.00(0.0%)
Dec 1999
$60.80M(-78.9%)
-
-
Dec 1999
-
$0.00(0.0%)
$0.00(0.0%)
Sep 1999
-
$0.00(0.0%)
$0.00(0.0%)
Jun 1999
-
$0.00(0.0%)
$0.00(0.0%)
Mar 1999
-
$0.00(0.0%)
$0.00(0.0%)
Dec 1998
$288.20M
-
-
Dec 1998
-
$0.00
$0.00

FAQ

  • What is Elevance Health, Inc. annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Elevance Health, Inc.?
  • What is Elevance Health, Inc. annual EBIT year-on-year change?
  • What is Elevance Health, Inc. quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Elevance Health, Inc.?
  • What is Elevance Health, Inc. quarterly EBIT year-on-year change?
  • What is Elevance Health, Inc. TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Elevance Health, Inc.?
  • What is Elevance Health, Inc. TTM EBIT year-on-year change?

What is Elevance Health, Inc. annual earnings before interest & taxes?

The current annual EBIT of ELV is $7.90B

What is the all time high annual EBIT for Elevance Health, Inc.?

Elevance Health, Inc. all-time high annual earnings before interest & taxes is $7.92B

What is Elevance Health, Inc. annual EBIT year-on-year change?

Over the past year, ELV annual earnings before interest & taxes has changed by +$189.00M (+2.45%)

What is Elevance Health, Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of ELV is $2.29B

What is the all time high quarterly EBIT for Elevance Health, Inc.?

Elevance Health, Inc. all-time high quarterly earnings before interest & taxes is $4.34B

What is Elevance Health, Inc. quarterly EBIT year-on-year change?

Over the past year, ELV quarterly earnings before interest & taxes has changed by -$694.00M (-23.24%)

What is Elevance Health, Inc. TTM earnings before interest & taxes?

The current TTM EBIT of ELV is $7.07B

What is the all time high TTM EBIT for Elevance Health, Inc.?

Elevance Health, Inc. all-time high TTM earnings before interest & taxes is $8.58B

What is Elevance Health, Inc. TTM EBIT year-on-year change?

Over the past year, ELV TTM earnings before interest & taxes has changed by -$1.51B (-17.62%)
On this page